Sally Wetten

1.7k total citations
29 papers, 837 citations indexed

About

Sally Wetten is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, Sally Wetten has authored 29 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Sally Wetten's work include Multiple Myeloma Research and Treatments (8 papers), Platelet Disorders and Treatments (3 papers) and Alzheimer's disease research and treatments (3 papers). Sally Wetten is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Platelet Disorders and Treatments (3 papers) and Alzheimer's disease research and treatments (3 papers). Sally Wetten collaborates with scholars based in United Kingdom, Switzerland and Italy. Sally Wetten's co-authors include R. Harling, Shahed Murad, Margaret Johnson, Julia Smedley, John Watson, Susan Munro, Andrew Hayward, Gwenda Hughes, Kate Soldan and Danilo Guzman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sally Wetten

26 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally Wetten United Kingdom	13	404	176	112	108	98	29	837
Tania Siahanidou Greece	19	313 0.8×	33 0.2×	32 0.3×	83 0.8×	119 1.2×	76	1.1k
Po‐Jen Cheng Taiwan	22	306 0.8×	70 0.4×	74 0.7×	34 0.3×	362 3.7×	123	1.6k
Prabha H. Andraweera Australia	21	218 0.5×	54 0.3×	20 0.2×	84 0.8×	138 1.4×	75	1.3k
Sen Hee Tay Singapore	19	134 0.3×	68 0.4×	57 0.5×	52 0.5×	36 0.4×	53	1.4k
Claire T. Deakin United Kingdom	15	504 1.2×	65 0.4×	40 0.4×	40 0.4×	76 0.8×	46	1.6k
Stuart J. Brink United States	20	315 0.8×	39 0.2×	45 0.4×	100 0.9×	54 0.6×	56	1.6k
Michael Marcy United States	7	252 0.6×	172 1.0×	48 0.4×	64 0.6×	22 0.2×	8	534
Ditte Mølgaard‐Nielsen Denmark	15	443 1.1×	200 1.1×	11 0.1×	53 0.5×	425 4.3×	25	1.1k
Carla Felice Italy	19	573 1.4×	20 0.1×	89 0.8×	40 0.4×	79 0.8×	80	1.6k
Laney S. Light United States	12	237 0.6×	132 0.8×	10 0.1×	71 0.7×	135 1.4×	15	684

Countries citing papers authored by Sally Wetten

Since Specialization

Citations

This map shows the geographic impact of Sally Wetten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Wetten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Wetten more than expected).

Fields of papers citing papers by Sally Wetten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Wetten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Wetten. The network helps show where Sally Wetten may publish in the future.

Co-authorship network of co-authors of Sally Wetten

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Wetten. A scholar is included among the top collaborators of Sally Wetten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Wetten. Sally Wetten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leleu, Xavier, Eirini Katodritou, Evangelos Terpos, et al.. (2022). Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel. SHILAP Revista de lepidopterología. 4(1). 174–183. 5 indexed citations

Terpos, Evangelos, Renato Zambello, Xavier Leleu, et al.. (2022). Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe. Cancers. 14(21). 5311–5311. 5 indexed citations

Desgraz, Renaud, et al.. (2020). Patient's Preference for Making Informed Treatment Decisions Confidently: Results from a Large Multiple Myeloma Patient Survey across 12 Countries in Europe and Israel. Blood. 136(Supplement 1). 23–23.

Terpos, Evangelos, Borhane Slama, Renato Zambello, et al.. (2020). Real-World Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients with at Least One Prior Therapy across 10 European Countries and Israel. Blood. 136(Supplement 1). 38–39. 4 indexed citations

Caers, Jo, Xavier Leleu, Barbara Gamberi, et al.. (2019). Real-World Use of Carfilzomib Therapy Among Patients With Existing Cardiovascular Medical History: An Analysis of a Prospective Observational Study. Clinical Lymphoma Myeloma & Leukemia. 19(10). e281–e282.

Terpos, Evangelos, Xavier Leleu, Barbara Gamberi, et al.. (2019). Real-World Evidence of the Use of Carfilzomib and Dexamethasone According to Age Subgroup: An Interim Analysis From a Prospective Observational Study. Clinical Lymphoma Myeloma & Leukemia. 19(10). e282–e283.

Giebel, Sebastian, Ariane Boumendil, Myriam Labopin, et al.. (2019). Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Annals of Hematology. 98(10). 2389–2398. 15 indexed citations

Šmakal, Martin, et al.. (2018). Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin’s lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study. Supportive Care in Cancer. 27(4). 1449–1457. 6 indexed citations

Schipperus, Martin R., et al.. (2018). Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study. Drug Safety. 42(1). 77–83. 7 indexed citations

10.

Vitolo, Umberto, et al.. (2016). G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin’s lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy. Medical Oncology. 33(12). 139–139. 7 indexed citations

11.

Cetin, Karynsa, Ivy Altomare, Sally Wetten, & Jeffrey S. Wasser. (2016). Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US. Clinical Epidemiology. 8. 231–231. 19 indexed citations

12.

Wetten, Sally, et al.. (2015). Diagnosis and treatment of chlamydia and gonorrhoea in general practice in England 2000–2011: a population-based study using data from the UK Clinical Practice Research Datalink. BMJ Open. 5(5). e007776–e007776. 31 indexed citations

13.

Wetten, Sally, et al.. (2015). Comparative Effectiveness Of Granulocyte Colony-Stimulating Factors (G-Csf) For Reducing Incidence Of Febrile Neutropenia (Fn) –Related Hospitalization: A Retrospective Cohort Study Using German Claims Data. Value in Health. 18(7). A434–A434. 4 indexed citations

14.

Savage, Emma, et al.. (2012). P96 Characteristics and sexual health outcomes of sex workers seeking sexual health care in England. Sexually Transmitted Infections. 88(Suppl 1). A42.1–A42. 1 indexed citations

15.

McHugh, Simon, Shilina Roman, Annelize Koch, et al.. (2012). Effects of genetic variation in the P2RX7 gene on pharmacodynamics of a P2X₇ receptor antagonist: a prospective genotyping approach. British Journal of Clinical Pharmacology. 74(2). 376–380. 18 indexed citations

16.

Craigen, Jenny, Wendy J.M. Mackus, Sam R. Miller, et al.. (2009). Ofatumumab, a Human Mab Targeting a Membrane-Proximal Small-Loop Epitope On CD20, Induces Potent NK Cell-Mediated ADCC.. Blood. 114(22). 1725–1725. 20 indexed citations

17.

Davidson, Julie, Michael C. Irizarry, Bethany C. Bray, et al.. (2009). An exploration of cognitive subgroups in Alzheimer’s disease. Journal of the International Neuropsychological Society. 16(2). 233–243. 35 indexed citations

18.

Filippini, Nicola, Anil Rao, Sally Wetten, et al.. (2008). Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease. NeuroImage. 44(3). 724–728. 123 indexed citations

19.

Wetten, Sally, et al.. (2007). Vector competence for Onchocerca volvulus in the Simulium (Notolepria) exiguum complex: Cytoforms or density-dependence?. Acta Tropica. 103(1). 58–68. 8 indexed citations

20.

Hayward, Andrew, R. Harling, Sally Wetten, et al.. (2006). Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 333(7581). 1241–1241. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact